Study on Early Lyme Neuroborreliosis
Clinical and Microbiological Parameters in Patients With Early Lyme Neuroborreliosis
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Dasa Stupica, MD
- Phone Number: +38615222110
- Email: cerar.dasa@gmail.com
Study Contact Backup
- Name: Franc Strle, MD
- Phone Number: +38615222110
- Email: franc.strle@kclj.si
Study Locations
-
-
-
Ljubljana, Slovenia, 1525
- Recruiting
- UMC Ljubljana, Department of Infectious Diseases
-
Principal Investigator:
- Dasa Stupica, M.D., PhD
-
Sub-Investigator:
- Katarina Ogrinc, M.D., PhD
-
Sub-Investigator:
- Eva Ruzic-Sabljic, M.D., PhD
-
Sub-Investigator:
- Tjasa Cerar, PhD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- erythema migrans within 4 months before neurologic involvement and pleocytosis in patients >15 years old
Exclusion Criteria:
- pregnancy
- lactation
- history of adverse reaction to a beta-lactam antibiotic
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Early Lyme neuroborreliosis patients
|
ceftriaxone 2 g od i.v. for 14 days
|
|
No Intervention: control subjects
Control subjects without a history of Lyme borreliosis.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Objective sequelae and post-treatment subjective symptoms in patients treated with ceftriaxone for early Lyme neuroborreliosis
Time Frame: 1 year follow-up
|
1 year follow-up
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Comparison of subjective symptoms between patients treated with ceftriaxone for early Lyme neuroborreliosis and control subjects without a history of Lyme borreliosis
Time Frame: 1 year follow-up
|
1 year follow-up
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Central Nervous System Diseases
- Nervous System Diseases
- Infections
- Central Nervous System Infections
- Vector Borne Diseases
- Gram-Negative Bacterial Infections
- Bacterial Infections
- Bacterial Infections and Mycoses
- Central Nervous System Bacterial Infections
- Tick-Borne Diseases
- Borrelia Infections
- Spirochaetales Infections
- Lyme Disease
- Lyme Neuroborreliosis
- Anti-Infective Agents
- Anti-Bacterial Agents
- Ceftriaxone
Other Study ID Numbers
Other Study ID Numbers
- LNB-0509
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.